Charmaine Lykins - Nov 29, 2021 Form 3 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Commercial Officer
Signature
/s/ Charmaine Lykins
Stock symbol
KRTX
Transactions as of
Nov 29, 2021
Transactions value $
$0
Form type
3
Date filed
11/30/2021, 04:11 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KRTX Stock Option (Right to Buy) Nov 29, 2021 Common Stock 75K $125.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on November 29, 2022, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.

Remarks:

Exhibit 24 - Power of Attorney